Elizabeth Garrett-Mayer, Vice President of Center for Research and Analytics at American Society of Clinical Oncology (ASCO), shared a post on LinkedIn:
“I’ll be a moderator for one of the panels at the Friends of Cancer Research meeting ‘Application of External Control Arms in Oncology Drug Development‘ on Tuesday, April 7, 2026.
This event brings together leaders across federal health and regulatory agencies, academic research, industry, and patient advocates to explore opportunities for advancing the use of external control arms (ECAs) to enhance oncology drug development, provide insights from Friends’ ongoing ECA research partnership, and address approaches that can support regulatory decision-making and help expand patient access to promising treatments.”
Other articles featuring Elizabeth Garrett-Mayer on OncoDaily.